» Articles » PMID: 30941733

Secretome of Mesenchymal Stem Cells and Its Potential Protective Effects on Brain Pathologies

Overview
Journal Mol Neurobiol
Date 2019 Apr 4
PMID 30941733
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have indicated that mesenchymal stem cells (MSCs) have a fundamental role in the repair and regeneration of damaged tissues. There is strong evidence showing that much of the beneficial effects of these cells are due to the secretion of bioactive molecules-besides microRNAs, hormones, and neurotrophins-with anti-inflammatory, immunoregulatory, angiogenic, and trophic effects. These factors have been reported by many studies to possess protective effects on the nervous tissue. Although the beneficial effects of the secretory factors of MSCs have been suggested for various neurological diseases, their actions on astrocytic cells are not well understood. Hence, it is important to recognize the specific effects of MSCs derived from adipose tissue, in addition to the differences presented by the secretome, depending on the source and methods of analysis. In this paper, the different sources of MSCs and their main characteristics are described, as well as the most significant advances in regeneration and protection provided by the secretome of MSCs. Also, we discuss the possible neuroprotective mechanisms of action of the MSC-derived biomolecules, with special emphasis on the effect of MSCs derived from adipose tissue and their impact on glial cells and brain pathologies.

Citing Articles

Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer's, Parkinson's, and ALS.

Toader C, Tataru C, Munteanu O, Serban M, Covache-Busuioc R, Ciurea A Int J Mol Sci. 2024; 25(23.

PMID: 39684324 PMC: 11641752. DOI: 10.3390/ijms252312613.


Multi-omics evaluation of clinical-grade human umbilical cord-derived mesenchymal stem cells in synergistic improvement of aging related disorders in a senescence-accelerated mouse model.

Lian J, Xia L, Wang G, Wu W, Yi P, Li M Stem Cell Res Ther. 2024; 15(1):383.

PMID: 39468666 PMC: 11520580. DOI: 10.1186/s13287-024-03986-9.


Conditioned Medium Derived From the Human Amniotic Membrane Prevents Brain Damage Against Cerebral Ischemia/Reperfusion in Subacute, Acute, and Chronic Phases in a Rat Model of Stroke.

Razavi-Toosi S, Asadi Y, Aboutaleb N, Faezi M Basic Clin Neurosci. 2024; 14(6):843-856.

PMID: 39070200 PMC: 11273199. DOI: 10.32598/bcn.2023.5693.1.


Mechanistic advances of hyperoxia-induced immature brain injury.

Song Y, Yang C Heliyon. 2024; 10(9):e30005.

PMID: 38694048 PMC: 11058899. DOI: 10.1016/j.heliyon.2024.e30005.


Reactive Gliosis in Neonatal Disorders: Friend or Foe for Neuroregeneration?.

Gargas J, Janowska J, Gebala P, Maksymiuk W, Sypecka J Cells. 2024; 13(2).

PMID: 38247822 PMC: 10813898. DOI: 10.3390/cells13020131.


References
1.
Koc O, Gerson S, Cooper B, Dyhouse S, Haynesworth S, Caplan A . Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000; 18(2):307-16. DOI: 10.1200/JCO.2000.18.2.307. View

2.
Vessey C, de la Hall P . Hepatic stem cells: a review. Pathology. 2001; 33(2):130-41. View

3.
Toma C, Pittenger M, Cahill K, Byrne B, Kessler P . Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105(1):93-8. DOI: 10.1161/hc0102.101442. View

4.
Chen Y, Swanson R . Astrocytes and brain injury. J Cereb Blood Flow Metab. 2003; 23(2):137-49. DOI: 10.1097/01.WCB.0000044631.80210.3C. View

5.
De Ugarte D, Morizono K, Elbarbary A, Alfonso Z, ZuK P, Zhu M . Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs. 2003; 174(3):101-9. DOI: 10.1159/000071150. View